Episode #94 | Advances in Biomaterials for Medical 3D Printing (Virtual Event Recording)

What truly makes bioprinting possible isn’t just 3D printers. It's important to understand the materials that flow through them. In this virtual event, we explored the world of biomaterials for tissue engineering and how chemists are shaping the future of regenerative medicine through careful material design. On demand course: https://3dheals.com/courses/advanced-biomaterials-for-3d-printed-medtech-and-biotech/ YouTube highlights: Here Our editorial event recap: https://3dheals.com/what-are-the-latest-advances-in-biomaterials-for-3d-bioprinting/ Bowman Bagley, Vice President of Commercial at CollPlant, introduces recombinant human collagen made from genetically modified tobacco plants. This approach avoids animal-derived components while improving performance. The collagen can be concentrated to higher levels and modified more effectively than traditional sources, producing structures that support tissue regeneration while staying printable. Dr. Janaina Dernowsek, Co-Founder and CEO, takes us inside the Quantis Biotechnology platform, where her team has developed a way to create human extracellular matrix (ECM) from bioprinted tissue constructs. By using dermal-like tissues as bioreactors, they harvest complex protein networks that promote cell growth without triggering inflammation, opening new possibilities for skin regeneration and beyond. Dr. Riccardo Levato, highlights volumetric bioprinting, a method that uses patterned light to form entire structures within seconds. His team combines material chemistry with advanced design techniques, allowing printers to respond to cellular environments in real time and build vascular networks that support tissue function. Dr. Jasper Van Hoorick, Co-Founder and CEO of BIO INX, addresses the need for standardization and confronts "biofabrication deception". He describes how his company creates consistent, high-performing materials tailored to specific printing technologies. This work helps make bioprinting more reliable and accessible for researchers worldwide. Finally, Dr. Scott Taylor, CTO at Poly-Med, discusses absorbable synthetic polymers that provide mechanical support during tissue regeneration and then safely degrade once their job is done. Whether you are a researcher, clinician, or industry professional, this episode highlights how material science is driving progress in bioprinting and bringing new possibilities to tissue engineering. Podcast Engineer: Faith Fernandes Send us Fan Mail Support the show Subscribe to our premium version and support the show. Follow us: Twitter Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D